Exome sequence identifies RIPK4 as the Bartsocas-Papas syndrome locus
Related Experiment Video
Updated: May 26, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Karen Mitchell1, James O'Sullivan, Caterina Missero
1Faculty of Medical and Human Sciences, Manchester Academic Health Sciences Centre, University of Manchester, UK.
Insights
Pterygium syndromes, rare genetic disorders causing skin webs, were linked to mutations in the RIPK4 gene. This research identifies RIPK4 as a key player in stratified epithelial development, crucial for preventing these conditions.
Area of Science:
- Genetics
- Developmental Biology
- Molecular Biology
Background:
- Pterygium syndromes are a group of complex congenital disorders characterized by skin webbing and craniofacial anomalies.
- Severe forms, like Bartsocas-Papas syndrome, often lead to early lethality, hindering genetic mutation identification.
Observation:
- Exome sequencing in a consanguineous family revealed a homozygous mutation (c.1127C>A) in the RIPK4 gene, leading to a nonsense mutation (p.Ser376X).
- A second mutation (c.242T>A) in RIPK4, causing a missense variant (p.Ile81Asn), was also identified in the kinase domain.
Findings:
- The identified RIPK4 mutations disrupt the ankyrin repeat-containing kinase, essential for keratinocyte differentiation.
- RIPK4 was demonstrated to be a direct transcriptional target of the p63 protein.
- p63 acts as a master regulator in stratified epithelial development, with RIPK4 being a nodal point in preventing pterygium syndromes.
Implications:
- This study elucidates the genetic basis of certain pterygium syndromes by identifying RIPK4 mutations.
- Understanding the RIPK4-p63 pathway provides crucial insights into stratified epithelial development.
- These findings pave the way for potential diagnostic and therapeutic strategies for pterygium syndromes.
Abstract:
Pterygium syndromes are complex congenital disorders that encompass several distinct clinical conditions characterized by multiple skin webs affecting the flexural surfaces often accompanied by craniofacial anomalies. In severe forms, such as in the autosomal-recessive Bartsocas-Papas syndrome, early lethality is common, complicating the identification of causative mutations. Using exome sequencing in a consanguineous family, we identified the homozygous mutation c.1127C>A in exon 7 of RIPK4 that resulted in the introduction of the nonsense mutation p.Ser376X into the encoded ankyrin repeat-containing kinase, a protein that is essential for keratinocyte differentiation. Subsequently, we identified a second mutation in exon 2 of RIPK4 (c.242T>A) that resulted in the missense variant p.Ile81Asn in the kinase domain of the protein. We have further demonstrated that RIPK4 is a direct transcriptional target of the protein p63, a master regulator of stratified epithelial development, which acts as a nodal point in the cascade of molecular events that prevent pterygium syndromes.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pleiotropy
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

